FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.

about

Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network.ATM deficiency promotes progression of CRPC by enhancing Warburg effect

P2860

Q55171826-06AF6D3D-83F5-4C6C-9FE3-AC266D5EFDD1 Q58542898-3DB63B24-4B40-4182-8371-0ED4169B799C

P2860

FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.

Item

http://www.wikidata.org/entity/Q38722718

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

FOXA2 is a sensitive and speci ...... ine carcinoma of the prostate.

@en

type

Item

label

FOXA2 is a sensitive and speci ...... ine carcinoma of the prostate.

@en

prefLabel

FOXA2 is a sensitive and speci ...... ine carcinoma of the prostate.

@en

P1476

FOXA2 is a sensitive and speci ...... rine carcinoma of the prostate

@en

P2093

Jiaoti Huang

http://www.w3.org/2001/XMLSchema#string

Jung Wook Park

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

P2860

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Expression of Foxa transcription factors in the developing and adult murine prostate

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.

Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers.

Small cell carcinoma of the prostate: an immunohistochemical study.

Humanized mice in translational biomedical research.

P2888

modpathol.2017.44

P304

1262-1272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2017.44

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John K Lee

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086043534

http://www.w3.org/2001/XMLSchema#string

P698

28621319

http://www.w3.org/2001/XMLSchema#string

P932

6330177

http://www.w3.org/2001/XMLSchema#string

FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.

about

P2860

P2860

FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932